GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TerrAscend Corp (TSX:TSND) » Definitions » Research & Development

TerrAscend (TSX:TSND) Research & Development : C$0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TerrAscend Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. TerrAscend's Research & Development for the three months ended in Dec. 2023 was C$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.0 Mil.

TerrAscend Research & Development Historical Data

The historical data trend for TerrAscend's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TerrAscend Research & Development Chart

TerrAscend Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 0.77 0.17 - - -

TerrAscend Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TerrAscend Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TerrAscend  (TSX:TSND) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

TerrAscend Research & Development Related Terms

Thank you for viewing the detailed overview of TerrAscend's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

TerrAscend (TSX:TSND) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TerrAscend Corp (TSX:TSND) » Definitions » Research & Development
Comparable Companies
TSX:DHT.U TSX:WEED XCNQ:CL TSX:GUD NEOE:GLAS.A.U TSX:CRON XCNQ:AAWH.U TSX:ACB XCNQ:EPIC XCNQ:IAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
TSNDF:USA TED:Germany
Address
3610 Mavis Road, Mississauga, ON, CAN, L5C 1W2
Website
https://www.terrascend.com
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.
Executives
Jason Wild 10% Security Holder, Director

TerrAscend (TSX:TSND) Headlines

No Headlines